Oklo stock seen rising 77% with regulatory progress and key partnerships boosting outlook despite recent losses.

Oklo shares have fallen recently due to a net loss reported in Q1 2026, but the company holds strong liquidity and gained regulatory approval for its Aurora nuclear reactor design. Analysts see significant upside potential, with a 24/7 Wall St. price target of $98.78, implying a 76.77% increase from current levels. Key partnerships with major tech firms and upcoming milestones could drive further gains, though risks remain from dilution and execution challenges. Investors are advised to consider this a cautious buy, especially if they can tolerate volatility and wait for revenue growth expected by 2028.